EVGN (Evogene, Ltd.) סך נכסי החברה

Evogene Ltd. (EVGN) optimizes the development of pharmaceuticals and new plant varieties using AI, generating high margins through licensing. The company serves as a technological ally for leaders in the medical and agricultural sectors by providing them with shared computing power. This chart illustrates that the asset's market value on the GURU.Markets platform is 12.77, while the holding's risks are mitigated through bio-product diversification and a streamlined model for transferring rights to subsidiaries.

Evogene Ltd. (EVGN) expansion into the AI-biology market and the broadening of its international agricultural holding base directly scale the issuer's resource base. By analyzing changes in the company's financial assets, an investor observes the aggregate of capital and liabilities, reverse-calculated via ROA, which allows for the differentiation of organic infrastructure growth from stagnation, thereby determining the long-term fundamental stability and maturity of the business.